Release Date: 13/04/11 18:13 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 163.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%